Cord blood infusions aim to slow Alzheimer's decline
NCT ID NCT07208344
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tests if infusions of cells from umbilical cord blood can improve cognitive function in people with mild-to-moderate Alzheimer's disease. Thirty participants will receive either a low dose, high dose, or a placebo (saline) infusion weekly for four weeks, plus a fifth infusion a month later. Researchers will track changes in memory, daily living skills, and blood markers over six months to see if the treatment is safe and shows promise.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of the University of Science and Technology of China
RECRUITINGHefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.